Invesco Ltd. Arcus Biosciences, Inc. Transaction History

Invesco Ltd.

$499 Billion
Q3 2024

A detailed history of Invesco Ltd. transactions in Arcus Biosciences, Inc. stock. As of the latest transaction made, Invesco Ltd. holds 168,082 shares of RCUS stock, worth $2.51 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

168,082

Previous 182,440 7.87%

Holding current value

$2.51 Million

Previous $2.78 Million 7.52%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$13.69 - $18.01 $196,561 - $258,587	-14,358 Reduced 7.87%	168,082 $2.57 Million
Q2 2024 Aug 13, 2024	SELL	$14.59 - $18.48 $120,265 - $152,330	-8,243 Reduced 4.32%	182,440 $2.78 Million
Q1 2024 May 14, 2024	SELL	$14.83 - $20.18 $28,874 - $39,290	-1,947 Reduced 1.01%	190,683 $3.6 Million
Q4 2023 Feb 12, 2024	SELL	$13.43 - $19.63 $539,536 - $788,615	-40,174 Reduced 17.26%	192,630 $3.68 Million
Q3 2023 Nov 13, 2023	SELL	$17.62 - $23.54 $288,280 - $385,137	-16,361 Reduced 6.57%	232,804 $4.18 Million
Q2 2023 Aug 11, 2023	SELL	$16.97 - $22.03 $576,199 - $748,006	-33,954 Reduced 11.99%	249,165 $5.06 Million
Q1 2023 May 12, 2023	BUY	$15.96 - $23.15 $173,022 - $250,969	10,841 Added 3.98%	283,119 $5.16 Million
Q4 2022 Feb 13, 2023	BUY	$19.7 - $35.71 $113,550 - $205,832	5,764 Added 2.16%	272,278 $5.63 Million
Q3 2022 Nov 14, 2022	SELL	$23.23 - $30.07 $1.72 Million - $2.23 Million	-74,250 Reduced 21.79%	266,514 $6.97 Million
Q2 2022 Aug 15, 2022	BUY	$17.23 - $37.73 $814,806 - $1.78 Million	47,290 Added 16.11%	340,764 $8.64 Million
Q1 2022 May 16, 2022	BUY	$28.92 - $41.83 $2.74 Million - $3.97 Million	94,844 Added 47.75%	293,474 $9.26 Million
Q4 2021 Feb 14, 2022	SELL	$31.38 - $48.47 $817,574 - $1.26 Million	-26,054 Reduced 11.6%	198,630 $8.04 Million
Q3 2021 Nov 15, 2021	BUY	$26.93 - $37.68 $170,493 - $238,552	6,331 Added 2.9%	224,684 $7.83 Million
Q2 2021 Aug 17, 2021	SELL	$22.75 - $35.77 $1.81 Million - $2.84 Million	-79,524 Reduced 26.7%	218,353 $6 Million
Q1 2021 May 17, 2021	SELL	$26.16 - $41.39 $180,006 - $284,804	-6,881 Reduced 2.26%	297,877 $8.36 Million
Q4 2020 Feb 16, 2021	BUY	$17.0 - $32.36 $314,364 - $598,401	18,492 Added 6.46%	304,758 $7.91 Million
Q3 2020 Nov 16, 2020	SELL	$17.14 - $25.47 $88,785 - $131,934	-5,180 Reduced 1.78%	286,266 $4.91 Million
Q2 2020 Aug 14, 2020	BUY	$13.97 - $36.56 $72,015 - $188,466	5,155 Added 1.8%	291,446 $7.21 Million
Q1 2020 May 15, 2020	BUY	$8.78 - $19.28 $2.51 Million - $5.52 Million	286,291 New	286,291 $3.97 Million

Others Institutions Holding RCUS

# of Institutions

200

Shares Held

51.5M

Call Options Held

236K

Put Options Held

141K

View Full List

About Arcus Biosciences, Inc.

Ticker RCUS
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 72,160,000
Market Cap $1.08B
Description
Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. Its product pipeline includes, Etrumadenant, a dual A2a/A2b adenosine receptor antagonist, which is in a Phase 1b/2 clinical trial; and Zimberelimab, an anti-PD-1 antibody that is in Phase 1b clinical trial for ...

More about RCUS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account